Insider · CIK 0001724310

Watts Ryan J.

CIK 0001724310 Name as filed on the most recent filing

Filed as Watts Ryan J. (51)

122 transaction lines · from 51 filings · filed 2018-08-31 to 2026-01-08 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

122 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-01-06 S, Open-market sale Denali Therapeutics Inc.DNLI 580,767, disposed Open Form 4 filing 0001724310-26-000004
2025-07-09 S, Open-market sale Denali Therapeutics Inc.DNLI 7,429,230, disposed Open Form 4 filing 0001714899-25-000149
2025-01-07 S, Open-market sale Denali Therapeutics Inc.DNLI 159,197, disposed Open Form 4 filing 0001714899-25-000049
2025-01-06 S, Open-market sale Denali Therapeutics Inc.DNLI 591,759, disposed Open Form 4 filing 0001714899-25-000049
2024-10-18 S, Open-market sale Denali Therapeutics Inc.DNLI 1,107,600, disposed Open Form 4 filing 0001714899-24-000206
2024-08-20 S, Open-market sale Denali Therapeutics Inc.DNLI 53,765, disposed Open Form 4 filing 0001714899-24-000197
2024-02-13 S, Open-market sale Denali Therapeutics Inc.DNLI 165,794, disposed Open Form 4 filing 0001714899-24-000061
2024-01-09 S, Open-market sale Denali Therapeutics Inc.DNLI 154,640, disposed Open Form 4 filing 0001714899-24-000039
2024-01-05 S, Open-market sale Denali Therapeutics Inc.DNLI 339,695, disposed Open Form 4 filing 0001714899-24-000035
2023-08-21 S, Open-market sale Denali Therapeutics Inc.DNLI 52,160, disposed Open Form 4 filing 0001714899-23-000133
2023-08-10 S, Open-market sale Denali Therapeutics Inc.DNLI 63,226, disposed Open Form 4 filing 0001714899-23-000123
2023-06-16 S, Open-market sale Denali Therapeutics Inc.DNLI 1,570,000, disposed Open Form 4 filing 0001714899-23-000105
2023-04-21 S, Open-market sale Denali Therapeutics Inc.DNLI 623,720, disposed Open Form 4 filing 0001714899-23-000066
2023-04-20 S, Open-market sale Denali Therapeutics Inc.DNLI 5,000, disposed Open Form 4 filing 0001714899-23-000066
2023-02-13 S, Open-market sale Denali Therapeutics Inc.DNLI 2 lines 1,017,243, disposed Open Form 4 filing 0001714899-23-000029
2023-02-10 S, Open-market sale Denali Therapeutics Inc.DNLI 727,500, disposed Open Form 4 filing 0001714899-23-000023
2023-02-09 S, Open-market sale Denali Therapeutics Inc.DNLI 105,015, disposed Open Form 4 filing 0001714899-23-000023
2023-01-05 S, Open-market sale Denali Therapeutics Inc.DNLI 136,512, disposed Open Form 4 filing 0001714899-23-000013
2023-01-04 S, Open-market sale Denali Therapeutics Inc.DNLI 144,483, disposed Open Form 4 filing 0001209191-23-002179
2022-08-19 S, Open-market sale Denali Therapeutics Inc.DNLI 79,861, disposed Open Form 4 filing 0001714899-22-000129
2022-02-11 S, Open-market sale Denali Therapeutics Inc.DNLI 329,528, disposed Open Form 4 filing 0001714899-22-000042
2022-02-09 S, Open-market sale Denali Therapeutics Inc.DNLI 102,104, disposed Open Form 4 filing 0001714899-22-000035
2022-01-05 S, Open-market sale Denali Therapeutics Inc.DNLI 224,213, disposed Open Form 4 filing 0001714899-22-000008
2021-12-01 S, Open-market sale Denali Therapeutics Inc.DNLI 3 lines 823,581, disposed Open Form 4 filing 0001714899-21-000114
2021-11-01 S, Open-market sale Denali Therapeutics Inc.DNLI 2 lines 912,176, disposed Open Form 4 filing 0001714899-21-000097
2021-10-01 S, Open-market sale Denali Therapeutics Inc.DNLI 3 lines 923,550, disposed Open Form 4 filing 0001714899-21-000093
2021-09-01 S, Open-market sale Denali Therapeutics Inc.DNLI 2 lines 1,002,012, disposed Open Form 4 filing 0001714899-21-000089
2021-08-19 S, Open-market sale Denali Therapeutics Inc.DNLI 2 lines 117,769, disposed Open Form 4 filing 0001714899-21-000085
2021-08-02 S, Open-market sale Denali Therapeutics Inc.DNLI 2 lines 942,477, disposed Open Form 4 filing 0001714899-21-000080
2021-07-01 S, Open-market sale Denali Therapeutics Inc.DNLI 3 lines 1,416,300, disposed Open Form 4 filing 0001209191-21-045422
2021-06-01 S, Open-market sale Denali Therapeutics Inc.DNLI 4 lines 1,125,648, disposed Open Form 4 filing 0001209191-21-037981
2021-05-03 S, Open-market sale Denali Therapeutics Inc.DNLI 3 lines 1,075,102, disposed Open Form 4 filing 0001209191-21-030300
2021-04-01 S, Open-market sale Denali Therapeutics Inc.DNLI 484,356, disposed Open Form 4 filing 0001209191-21-025115
2021-04-01 S, Open-market sale Denali Therapeutics Inc.DNLI 290,486, disposed Open Form 4 filing 0001209191-21-025115

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 122
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Watts Ryan J., insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001724310

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.